APA (7th ed.) Citation

YK, C., M, O., SP, P., FJ, B., DM, O., M, C., . . . R, K. (2026). DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: Clear cell carcinomas of ovary, endometrium, cervix. Journal for immunotherapy of cancer, 14(2), . https://doi.org/10.1136/jitc-2025-012805

Chicago Style (17th ed.) Citation

YK, Chae, et al. "DART/SWOG/NCI Phase II Anti-CTLA-4/PD-1 Trial: Clear Cell Carcinomas of Ovary, Endometrium, Cervix." Journal for Immunotherapy of Cancer 14, no. 2 (2026). https://doi.org/10.1136/jitc-2025-012805.

MLA (9th ed.) Citation

YK, Chae, et al. "DART/SWOG/NCI Phase II Anti-CTLA-4/PD-1 Trial: Clear Cell Carcinomas of Ovary, Endometrium, Cervix." Journal for Immunotherapy of Cancer, vol. 14, no. 2, 2026, https://doi.org/10.1136/jitc-2025-012805.